Experiment 14475

Worktypes

PHARMACOLOGY OF COMPOUND - IN VIVOWORK DESCRIBED MAINLY CONCERNS METHODOLOGYANTICANCER AND/OR CYTOTOXICITY MARKER CODEISOLATION AND IDENTIFICATION OFPATENT DESCRIBEDWORK DESCRIBED CONCERNS EXTRACTION/SEPARATION TECHNIQUES

Compounds isolated

LEUROSINE

Details

PropertyValue
Pharmacology
ANTITUMOR ACTIVITY
Administration routeIP
OrganismCatharanthus roseus (APOCYNACEAE)
CitationSVOBODA,GH:. (1968). LEUROSINE.. ()
Amount utilized
Compound isolated
Dose amount15.0 MG
Number5
Percent yield49%
Qualitative resultACTIVE
AnimalRAT
Per unitKG
Dose expressionDOSE
Expression resultTWD